These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. The Bile Acid-Phospholipid Conjugate Ursodeoxycholyl-Lysophosphatidylethanolamide (UDCA-LPE) Disintegrates the Lipid Backbone of Raft Plasma Membrane Domains by the Removal of the Membrane Phospholipase A2. Stremmel W; Staffer S; Fricker G; Weiskirchen R Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31717968 [TBL] [Abstract][Full Text] [Related]
9. Oleic Acid Protects against Hepatic Ischemia and Reperfusion Injury in Mice by Inhibiting AKT/mTOR Pathways. Guo J; Zhang T; Gu J; Cai K; Deng X; Chen K; Huang K; Wang G; Li H; Wang J Oxid Med Cell Longev; 2019; 2019():4842592. PubMed ID: 31915509 [TBL] [Abstract][Full Text] [Related]
10. Comparison of different bile acid-phospholipid conjugates in acute hepatitis. Pathil A; Warth A; Chamulitrat W; Stremmel W Eur J Clin Invest; 2012 Feb; 42(2):130-8. PubMed ID: 21707612 [TBL] [Abstract][Full Text] [Related]
11. Ursodeoxycholyl lysophosphatidylethanolamide improves steatosis and inflammation in murine models of nonalcoholic fatty liver disease. Pathil A; Mueller J; Warth A; Chamulitrat W; Stremmel W Hepatology; 2012 May; 55(5):1369-78. PubMed ID: 22183915 [TBL] [Abstract][Full Text] [Related]
12. Ursodeoxycholyl lysophosphatidylethanolamide attenuates hepatofibrogenesis by impairment of TGF-β1/Smad2/3 signalling. Pathil A; Mueller J; Ludwig JM; Wang J; Warth A; Chamulitrat W; Stremmel W Br J Pharmacol; 2014 Nov; 171(22):5113-26. PubMed ID: 25041068 [TBL] [Abstract][Full Text] [Related]